AlphaStocks
7.1
Consider Buy

AVANOS MEDICAL, INC. (AVNS)

Health Care / Health Care Supplies

S&P SmallCap 600

$24.73

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#59out of 1125 in Health Care

Is AVANOS MEDICAL, INC. a Good Investment in 2026?

AVANOS MEDICAL, INC. (AVNS) scores 7.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates AVANOS MEDICAL, INC. as Strong. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 96%). AVANOS MEDICAL, INC. currently trades below its estimated fair value of $35, suggesting potential upside. AVANOS MEDICAL, INC. ranks #59 out of 1125 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E12.5ROE5.4Market Cap1B

Estimated Fair Value

$35.3330% below

Fair value above market price. P/E of 12x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Attractive

39% below fair value

Lynch

Strong

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 96%)

Frequently Asked Questions

Is AVANOS MEDICAL, INC. (AVNS) a good investment?
Based on AlphaStocks' composite analysis, AVANOS MEDICAL, INC. (AVNS) scores 7.1 out of 10, earning a Consider Buy rating. This places it above average across most investment dimensions. Fair value above market price. P/E of 12x is moderate for this quality level.
What is AVANOS MEDICAL, INC.'s Piotroski F-Score?
AVANOS MEDICAL, INC.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AVNS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $35, AVNS appears undervalued. The stock currently trades 30% below its estimated fair value. Fair value above market price. P/E of 12x is moderate for this quality level.
How does AVNS compare to other Health Care stocks?
AVANOS MEDICAL, INC. ranks #59 out of 1125 stocks in the Health Care sector, placing it in the top 5% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about AVNS?
AlphaStocks evaluates AVNS using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Attractive; Lynch: Strong; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 7.1/10.

Similar Stocks

BFAMAZNKLIC

Compare AVNS with

AVNS vs BFAMAVNS vs AZNAVNS vs KLIC

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer